The mAb A13 specifically bound to a variety of tumor cells and human placenta tissues expressing EGFR. A13 efficiently inhibited both EGF-dependant EGFR tyrosine phosphorylation in cervical and breast tumor cells and also in vitro colony formation of EGFR-overexpressing lung tumors.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-056 | Recombinant Anti-Mouse Egfr VHH Single Domain Antibody | ELISA, IHC, FC, FuncS | Llama VHH |
HPAB-AP891-YC | Recombinant Llama Anti-EGFR Single Domain Antibody (HPAB-AP891-YC) | ELISA | Llama VHH |
HPAB-AP892-YC | Recombinant Llama Anti-EGFR Single Domain Antibody (HPAB-AP892-YC) | ELISA | Llama VHH |
HPAB-0705-YJ-VHH | Camelid Anti-EGFR Recombinant Single Domain Antibody (HPAB-0705-YJ-VHH) | ELISA, In vivo staining | Camelid VHH |
HPAB-0706-YJ-VHH | Camelid Anti-EGFR Recombinant Pentamer Single Domain Antibody (HPAB-0706-YJ-VHH) | ELISA, In vivo staining | Camelid Penta-VHH |
There are currently no Customer reviews or questions for HPAB-0727-CN-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.